CITADEL ADVISORS LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Back to LENZ Full portfolio

Position in LENZ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,063,140

+$2,063,140 QoQ

Shares Held

363,229

Ownership

1.16%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#22

of 143 holders

Holding Since

Jun 2021

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Derivatives in LENZ

reported options exposure · as of Jun 30, 2026

CallValue

$616,848

CallShares

108,600

PutValue

$617,984

PutShares

108,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. LENZ ranks #202 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

All Filings in LENZ

Export CSV

37 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$617,984	108,800	+38.8%	Put	Defined	2026-08-14
2026-06-30	$2,063,140	363,229	+350.8%	Shares	Defined	2026-08-14
2026-06-30	$616,848	108,600	+44.2%	Call	Defined	2026-08-14
2026-03-31	$717,360	78,400	-4.5%	Put	Defined	2026-05-15
2026-03-31	$688,995	75,300	+278.4%	Call	Defined	2026-05-15
2025-12-31	$318,400	19,900	+38.2%	Call	Defined	2026-02-17
2025-12-31	$1,313,600	82,100	+229.7%	Put	Defined	2026-02-17
2025-12-31	$1,289,184	80,574	-79.8%	Shares	Defined	2026-02-17
2025-09-30	$670,752	14,400	—	Call	Defined	2025-11-14
2025-09-30	$18,605,449	399,430	+4319.9%	Shares	Defined	2025-11-14
2025-09-30	$1,159,842	24,900	+139.4%	Put	Defined	2025-11-14
2025-06-30	$264,874	9,037	-5.8%	Shares	Defined	2025-08-14
2025-06-30	$304,824	10,400	—	Put	Defined	2025-08-14
2025-03-31	$246,661	9,594	—	Shares	Defined	2025-05-15
2023-12-31 GRPH	—	586,724	-52.8%	Shares	Defined	2024-02-14
2023-12-31 GRPH	—	1,700	+240.0%	Put	Defined	2024-02-14
2023-09-30 GRPH	—	500	-86.8%	Put	Defined	2023-11-14
2023-09-30 GRPH	—	700	-80.6%	Call	Defined	2023-11-14
2023-09-30 GRPH	—	1,242,459	+3.2%	Shares	Defined	2023-11-14
2023-06-30 GRPH	—	3,600	-53.2%	Call	Defined	2023-08-14
2023-06-30 GRPH	—	3,800	-65.5%	Put	Defined	2023-08-14
2023-06-30 GRPH	—	1,204,295	+2.8%	Shares	Defined	2023-08-14
2023-03-31 GRPH	—	7,700	-73.9%	Call	Defined	2023-05-15
2023-03-31 GRPH	—	1,171,177	-1.6%	Shares	Defined	2023-05-15
2023-03-31 GRPH	—	11,000	-50.5%	Put	Defined	2023-05-15
2022-12-31 GRPH	—	1,190,415	-6.6%	Shares	Defined	2023-02-14
2022-12-31 GRPH	—	22,200	-37.8%	Put	Defined	2023-02-14
2022-12-31 GRPH	—	29,500	-13.2%	Call	Defined	2023-02-14
2022-09-30 GRPH	—	1,274,047	-3.5%	Shares	Defined	2022-11-14
2022-09-30 GRPH	—	34,000	—	Call	Defined	2022-11-14
2022-09-30 GRPH	—	35,700	+205.1%	Put	Defined	2022-11-14
2022-06-30 GRPH	—	11,700	—	Put	Defined	2022-08-15
2022-06-30 GRPH	—	1,319,836	+5.2%	Shares	Defined	2022-08-15
2022-03-31 GRPH	—	1,254,694	+0.8%	Shares	Defined	2022-05-16
2021-12-31 GRPH	—	1,245,279	-2.0%	Shares	Defined	2022-02-14
2021-09-30 GRPH	—	1,270,173	-1.4%	Shares	Defined	2021-11-15
2021-06-30 GRPH	—	1,288,225	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.